.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Acute Myeloid Leukemia
Breast Cancer
CLL
CURE Ambassador Program
Kidney Cancer
Liver Cancer
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MPN
Myeloma
Ovarian Cancer
Publications
Skin Cancer

Cancer TypeSee All >

Bladder
Brain
Breast
Gastrointestinal
Gynecologic
Head & Neck
Lung
Lymphoma
Myeloma
Sarcoma
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise
Contact
TargetedOnc.com
OncLive.com
CancerNetwork.com
Terms & Conditions
Privacy
Do Not Sell My Information

BTK Inhibition for Waldenstrom Macroglobulinemia

EP. 1: The Nature of Waldenstrom Macroglobulinemia

February 15th 2019

EP. 2: Risk Factors in Developing Waldenstrom Macroglobulinemia

February 15th 2019

EP. 3: Waldenstrom Macroglobulinemia: Establishing a Diagnosis

February 15th 2019

EP. 4: Factors Impacting a Diagnosis and Prognosis of WM

February 15th 2019

EP. 5: Waldenstrom Macroglobulinemia: When to Initiate Therapy

February 15th 2019

EP. 6: A Historic Perspective on Frontline WM Management

February 15th 2019

EP. 7: Waldenstrom Macroglobulinemia: Evolving Frontline Treatment

February 15th 2019

EP. 8: Selecting Therapy Through Multiple Lines in WM

February 15th 2019

EP. 9: Targeted Approaches in Waldenstrom Macroglobulinemia

February 15th 2019

EP. 10: BTK Inhibitors in WM: Understanding Safety/Efficacy

February 15th 2019

Latest News

Novel App Informs Patients With Cancer of Unknown Primary

Giving Hope: Research on Rare Head and Neck Cancer Treatment Options

Searching For My Cancer Words

Pain Management Has Worsened for Patients With Late-Stage Cancer

View More Latest News